NEWS: Rosetta/NIH HIV collaboration

Following on from work showing that latent stage exit may be influenced by microRNA signalling, Rosetta is to leverage its intellectual property holdings in a collaboration with NIH
Pharmabiz

patent: LET-7 MICRORNA AND MIMETICS THEREOF AS THERAPEUTICS FOR CANCER

Treatment of cancer using let-7 or mimics. Treatment of cancer by replacing downregulated microRNAs. Using miRNAs to identify and enrich a population of cancer cells. blah blah blah.
WO/2008/095096
lab

A Functional Polymorphism in the miR-146a Gene and Age of Familial Breast/Ovarian Cancer Diagnosis.

[lab], [cta]